Abstract:ABSTRACT This work presents a multi-hurdle approach that addresses antimicrobial resistance by minimizing the selective pressure of antimicrobials using a novel colicinogenic–phage system. We have created two synthetic T7 phages (T7-E1 and T7-M) by inserting the gene of colicin E1 (Cea) or colicin M (Cma) into the genome of the T7 phage, thereby adding an additional colicin-based hurdle to the T7 lytic cycle. The colicin–phages' efficacy in suppressing the outgrowth of a T7-resistant sub-population within a mixed culture of Escherichia coli was demonstrated using a challenge matrix design under planktonic and structured conditions. When T7-resistant cells were present at 1% of the total planktonic population, T7-E1 delayed the outgrowth. At 0.1% resistance, T7-M delayed resistant outgrowth, whereas T7-E1 suppressed the resistant sub-population. When T7-E1 and T7-M were combined into a triple-hurdle treatment, the T7-E1/T7-M cocktail completely suppressed a mixed planktonic population of 50% resistance cell concentrations. In structured environments, the colicin–phage treatments formed clear and confluent plaque-like zones of clearing in the mixed populations of 50% resistant cells with a lawn density of 1 × 10 6 CFU/mL. Reducing the lawn density to 1 × 10 5 CFU/mL diminished the multi-hurdle treatments' effectiveness, as demonstrated by localized zones of clearing within turbid bacterial lawns, highlighting the relationship between bacterial lawn density and phage effectiveness in structured environments. Fluctuation assays revealed persistence as the predominant mechanism for overcoming the treatments by T7-sensitive E. coli . Results indicate that T7-M treatment significantly reduces persister formation compared to WT-T7, while T7-E1 unexpectedly increases persister formation significantly. This suggests a complex relationship between antimicrobial stress and persister formation. IMPORTANCE Antimicrobial resistance (AMR) poses a significant challenge in treating bacterial infections. To address this, we present a multi-hurdle approach that combines the power of different antimicrobials to target resistance. We have weaponized the natural predator of Escherichia coli , the T7-phage, by engineering it to produce toxins called colicins, resulting in a colicin–phage antimicrobial. This multi-hurdled approach aims to decrease resistance risk because survival requires different tactics to overcome the phage and colicin activity, thus adding a hurdle in a bacterium's pathway to resistance. In cases of pre-existing resistance, the colicin effectively controlled the sub-population resistant to the phage. When investigating the emergence of resistance, we discovered that antimicrobial persistence was the predominant survival strategy. These findings reveal an essential slice of the AMR pie by emphasizing bacterial survival tactics that are not based on resistance genes. By expanding our AMR lens to include persistence, we can more effectively address treatment failure.

Resistance to bacteriophage incurs a cost to virulence in drug-resistant Acinetobacter baumannii

Phage–Bacterial Interaction Alters Phenotypes Associated with Virulence in Acinetobacter baumannii

Variable fitness effects of bacteriophage resistance mutations in Escherichia coli: implications for phage therapy

Investigating Bacteriophages Targeting the Opportunistic Pathogen Acinetobacter baumannii

Bacteriophage Isolation, Purification, and Characterization Techniques Against Ubiquitous Opportunistic Pathogens

Phage therapy: A targeted approach to overcoming antibiotic resistance

Resistance Evolution against Phage Combinations Depends on the Timing and Order of Exposure

Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy

Phage‐resistant mutations impact bacteria susceptibility to future phage infections and antibiotic response

Resistance, mechanism, and fitness cost of specific bacteriophages for Pseudomonas aeruginosa

Two New Lytic Bacteriophages of the Myoviridae Family Against Carbapenem-Resistant Acinetobacter Baumannii

Resistance against two lytic phage variants attenuates virulence and antibiotic resistance in Pseudomonas aeruginosa

Breaking The Resistance: Bacteriophage "Novel" Pisf-Ab082 As An Alternative Treatment For Multidrug Resistant A. Baumannii

Temperate bacteriophage induced in Pseudomonas aeruginosa biofilms can modulate bacteriophage and antibiotic resistance

Survival Comes at a Cost: A Coevolution of Phage and Its Host Leads to Phage Resistance and Antibiotic Sensitivity of Pseudomonas aeruginosa Multidrug Resistant Strains

Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci

Lytic Bacteriophages Facilitate Antibiotic Sensitization of Enterococcus faecium

Parallel evolution of Pseudomonas aeruginosa phage resistance and virulence loss in response to phage treatment in vivo and in vitro

Phage-induced efflux down-regulation boosts antibiotic efficacy

Assessment of resistance to colicinogenic synthetic phage antimicrobial system

Experimental Phage Evolution Results in Expanded Host Ranges Against MDR and XDR Klebsiella pneumoniae Isolates